Public research preview
Josh Gottheimer, Representative disclosure: Arcutis Biotherapeutics, Inc. - Common stock (ARQT)
Disclosed a buy transaction in Arcutis Biotherapeutics, Inc. - Common stock (ARQT). Use this page to inspect source evidence, confidence scores, filing delay, and post-disclosure price movement before deciding whether to research the signal further.
This public page is for public-disclosure research only. It is not investment advice and does not place orders. Verify the official source before relying on any signal.
Evidence passport
Official-source context and parser confidence before any simulation or alert decision.
- Source
- House STOCK Act disclosures
- Published
- 22 Jul 2022, 00.00
- Parser confidence
- 94%
- Instrument mapping
- 95%
- Filing delay
- 37 days
Timeline
Transaction date
15 Jun 2022
Public disclosure
22 Jul 2022
Now
Tracked today
Filing delay: 37 days
Price movement
Complete coverage
- Provider
- Yahoo Finance daily close
- Fetched
- 10 Jun 2026
Most of the move happened before this disclosure became public: the stock peaked +24.6% above the transaction-date close and has since retraced -16.0% from that peak. Buying now is a pullback entry on the disclosed position, not a fresh breakout.
Stock path
ARQT from pre-transaction context through latest close.
Bought
15 Jun 2022 ยท 20,55 USD
- Observed transaction close
- 20,55
- Observed disclosure close
- 21,52
- Observed latest close
- 21,54
- Pre-disclosure move
- +4.7%
- Post-disclosure move
- +0.1%
- Market-adjusted move
- +0.1%
- Pre-disclosure peak run-up
- +24.6%
- Retrace from peak
- -16.0%
Why Copy Window is Probably too late
Supporting factors
- Parsed buy disclosure for ordinary shares from House STOCK Act disclosures.
- Reported amount is $1,001 - $15,000.
- Post-disclosure move is calculated from Yahoo Finance daily close daily closes.
Cautions
- Yahoo Finance daily close coverage is end-of-day and should be verified against the official price source.
- Review the original source document before making any investment decision.
Source document
House STOCK Act disclosures, published 22 Jul 2022, 00.00
- Parser confidence
- 94%
- Instrument mapping
- 95%